Even before a dementia diagnosis, people with mild cognitive impairment may have different changes in the brain depending on what type of dementia they have, according to a study published in the September 11, 2019, online ...
Sep 11, 2019
0
7
Many people who have problems with their memory, especially if they are elderly, worry that they have Alzheimer's disease, which afflicts at least 5.5 million people in the U.S. and brings tremendous burdens to families as ...
Aug 8, 2019
0
2
After Kim Lauerman was diagnosed with ovarian cancer, doctors wanted to give her a drug that helps prevent infections and fever during chemotherapy. Her insurer said no.
Jul 29, 2019
0
0
Researchers have completed a successful clinical trial, managing to detect and image radioactive tracers used in PET and in SPECT scans at the same time, with the hope of enabling doctors to scan patients for abnormalities ...
Jul 26, 2019
0
1
The abnormal accumulation of proteins in the brain is a biological marker for Alzheimer's disease, but the ways in which these proteins spread may help explain why the prevalence of Alzheimer's is higher in women than in ...
Jul 16, 2019
0
4
Secondary progressive multiple sclerosis (MS) is a relentless disease. Over time, patients experience worsening physical, mental and mood-related symptoms. And yet, even as their symptoms progress, the brain white matter ...
Jul 2, 2019
0
1
A single radiotracer can identify nearly 30 types of cancer, allowing for new applications in noninvasive diagnosis, staging and treatment, according to research presented at the 2019 Annual Meeting of the Society of Nuclear ...
Jun 26, 2019
0
0
Research presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) describes a new class of radiopharmaceuticals, named radiohybrids (rh), that offer a fresh perspective on cancer ...
Jun 25, 2019
0
2
New prostate cancer research shows that adding an interim scan during therapy can help guide a patient's treatment. Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) imaging of patients with metastatic ...
Jun 24, 2019
0
0
The strongest genetic risk factor for Alzheimer's disease is the apolipoprotein E type 4 allele (ApoE ε4). Research presented by Manish Paranjpe at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular ...
Jun 24, 2019
0
2
